Gerrit Stoter

Side Effects of Interferon-α Therapy

Stefan Sleijfer, S. Sleijfer, G. Stoter, 2005, Pharmacy World and Science.

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump.

Mariël Brok, A. W. Boersma, E. Wiemer, 2004, Blood.

Imatinib mesylate ( STI 571 ) is a substrate for the breast cancer resistance protein ( BCRP ) / ABCG 2 drug pump

Mariël Brok, A. W. Boersma, E. Wiemer, 2004 .

Molecular profiling of platinum resistant ovarian cancer

Maurice P H M Jansen, E. Berns, P. Span, 2006, International journal of cancer.

International germ cell consensus classification: A prognostic factor-erased staging system for metastatic germ cell cancers

Richard Sylvester, Andrew Kramar, Madhu Mazumdar, 1997 .